GGPS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.799600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.244000E-01
Normal-vs-Stage2
5.652200E-01
Normal-vs-Stage3
5.465000E-01
Normal-vs-Stage4
4.123800E-01
Stage1-vs-Stage2
7.384400E-01
Stage1-vs-Stage3
1.974180E-01
Stage1-vs-Stage4
7.098000E-01
Stage2-vs-Stage3
1.706010E-01
Stage2-vs-Stage4
4.133400E-01
Stage3-vs-Stage4
2.335800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.426800E-01
Normal-vs-AfricanAmerican
1.109650E-01
Normal-vs-Asian
4.635200E-01
Caucasian-vs-AfricanAmerican
9.097800E-02
Caucasian-vs-Asian
2.811600E-01
AfricanAmerican-vs-Asian
5.712200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.012200E-01
Normal-vs-Female
5.630400E-01
Male-vs-Female
8.523000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.263400E-01
Normal-vs-Age(41-60Yrs)
4.171800E-01
Normal-vs-Age(61-80Yrs)
6.385400E-01
Normal-vs-Age(81-100Yrs)
6.233000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.562390E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.366600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.973600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.812000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.799000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.829000E-01
Normal-vs-Daily Drinker
9.988800E-01
Normal-vs-Weekly Drinker
6.378400E-01
Normal-vs-Occasional Drinker
2.348800E-01
Normal-vs-Social Drinker
4.137000E-01
Non Drinker-vs-Daily Drinker
4.011800E-01
Non Drinker-vs-Weekly Drinker
9.161800E-01
Non Drinker-vs-Occasional Drinker
2.270200E-01
Non Drinker-vs-Social Drinker
6.097000E-01
Daily Drinker-vs-Weekly Drinker
4.255000E-01
Daily Drinker-vs-Occasional Drinker
5.529900E-02
Daily Drinker-vs-Social Drinker
2.156600E-01
Weekly Drinker-vs-Occasional Drinker
3.327600E-01
Weekly Drinker-vs-Social Drinker
7.188400E-01
Occasional Drinker-vs-Social Drinker
5.030800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.079700E-02
Normal-vs-Grade 2
1.838680E-03
Normal-vs-Grade 3
5.697900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.436190E-01
Grade 1-vs-Grade 3
2.767600E-01
Grade 1-vs-Grade 4
4.079700E-02
Grade 2-vs-Grade 3
8.510200E-01
Grade 2-vs-Grade 4
1.838680E-03
Grade 3-vs-Grade 4
5.697900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.627800E-01
Normal-vs-NonDiabetic
4.865600E-01
Diabetic-vs-NonDiabetic
2.096300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.521200E-01
Normal-vs-NoPancreatitis
6.040800E-01
Pancreatitis-vs-NoPancreatitis
8.930200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.963400E-01
Normal-vs-N1
6.268800E-01
N0-vs-N1
4.119600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.451840E-01
Normal-vs-TP53-NonMutant
4.655000E-01
TP53-Mutant-vs-TP53-NonMutant
1.692430E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
